Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia
Hyperkalemia after kidney transplantation is a common electrolyte disturbance and the risk factors are multifactorial. Pharmacotherapeutic agents for chronic management of hyperkalemia in kidney transplant patients may be relatively contraindicated or provide suboptimal efficacy. Fludrocortisone, an...
Saved in:
| Main Authors: | K. Marfo, D. Glicklich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2012/586859 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe metabolic alkalosis with fludrocortisone therapy—a case report
by: Grace Williams, et al.
Published: (2025-03-01) -
Fluid Selection in Renal Transplant Patients: Considerations for Hyperkalemia Management
by: Furkan Tontu
Published: (2025-06-01) -
A Rare Cause of Persistent Anemia in a Renal Transplant Recipient
by: Urmila Anandh, et al.
Published: (2023-07-01) -
WCN25-3657 TACROLIMUS INDUCED HYPONATREMIA TREATED WITH FLUDROCORTISONE
by: Shrikant Deshmukh, et al.
Published: (2025-02-01) -
Renal replacement therapy in heart transplant recipients
by: I. L. Poz, et al.
Published: (2022-01-01)